Lance Ballester
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lance Ballester has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Abdulla M. Ehlayel
Division of Nephrology, Children’s Hospital of New Orleans, New Orleans, USA
1 shared publication - Ammie M. White
Department of Radiology, Children’s Hospital of Philadelphia, 3401 Civic Center Blvd, Philadelphia, PA 19104
1 shared publication Bernarda Viteri
1 shared publicationDerick Ms Lim
Department of Pathology and Laboratory Medicine at The Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, PA
1 shared publication- Donald L. Boyer
Both authors: Department of Anesthesiology and Critical Care Medicine, Children’s Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
1 shared publication - Eloise Salmon
University of Michigan
1 shared publication
Latest Publications
- 1 April 2023
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 307 (1) , e210816
Risk of Acute Kidney Injury Following Contrast-enhanced CT in a Cohort of 10 407 Children and Adolescents
Acute kidney injury in this pediatric sample was lower than previously reported, with an overall incidence of 1.5%. Background Previous studies have challenged the concept of contrast material–induced acute kidney injury (AKI) in adults; however, limited data exist for children and adolescents. Purpose To calcul...
- 1 April 2023
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 307 (1) , e210816
Risk of Acute Kidney Injury Following Contrast-enhanced CT in a Cohort of 10 407 Children and Adolescents
Acute kidney injury in this pediatric sample was lower than previously reported, with an overall incidence of 1.5%. Background Previous studies have challenged the concept of contrast material–induced acute kidney injury (AKI) in adults; however, limited data exist for children and adolescents. Purpose To calcul...
- Open Access
- 1 January 2020
- Published by Wolters Kluwer Health in Critical Care Explorations
- Vol. 2 (1) , e0073
Vecuronium- and Esmolol-Induced Pseudohypernatremia Due to Drug Interference With Ion-Selective Electrodes
Objectives: We observed that patients treated with continuous vecuronium or esmolol infusions showed elevated plasma sodium measurements when measured by the routine chemistry analyzer as part of the basic metabolic panel (Vitros 5600; Ortho Clinical Diagnostics, Raritan, NJ), but not by blood gas analyzers (RAPIDLab 1265; Siemens, Tarrytown, NY). Both instruments use direct ion-selective electrode technology, albeit with different sodium ionophores (basic metabolic panel: methyl monensin, blood gas: glass). We questioned if the basic metabolic panel hypernatremia represents artefactual pseudohypernatremia. Design: We added vecuronium bromide or esmolol hydrochloric acid to pooled plasma samples and compared sodium values measured by both methodologies. We queried sodium results from the electronic medical records of patients admitted at Children’s Hospital of Philadelphia from 2016 to 2018 and received vecuronium and/or esmolol infusion treatment during their admissions. Setting: PICU of a quaternary, free-standing children’s hospital. Patients: Children admitted to the hospital who received vecuronium and/or esmolol infusion. Measurements and Main Results: Sodium was measured in pooled plasma samples by basic metabolic panel and blood gas methodologies after adding vecuronium bromide or esmolol hydrochloric acid, leading to a dose-response increase in basic metabolic panel sodium measurements. A repeated measures regression analysis of our electronic medical records showed that the vecuronium dose predicted the Δ sodium (basic metabolic panel–blood gas) sodium within 12 hours of the vecuronium administration (p < 0.0018). Esmolol showed a similar trend (p = 0.13). This occurred primarily in central line samples with continuous vecuronium or esmolol infusions. Conclusions: Vecuronium and esmolol can falsely elevate direct ion-selective electrode sodium measurements on Vitros chemistry analyzers. Unexpectedly high sodium measurements in patients receiving vecuronium and/or esmolol infusions should be further investigated with an alternate sample type (i.e., peripheral blood) or measurement methodology (i.e., blood gas) to guide treatment decisions.
- 1 January 2020
- Published by Wolters Kluwer Health in Critical Care Explorations
- Vol. 2 (1) , e0073
Open AccessVecuronium- and Esmolol-Induced Pseudohypernatremia Due to Drug Interference With Ion-Selective Electrodes
Objectives: We observed that patients treated with continuous vecuronium or esmolol infusions showed elevated plasma sodium measurements when measured by the routine chemistry analyzer as part of the basic metabolic panel (Vitros 5600; Ortho Clinical Diagnostics, Raritan, NJ), but not by blood gas analyzers (RAPIDLab 1265; Siemens, Tarrytown, NY). Both instruments use direct ion-selective electrode technology, albeit with different sodium ionophores (basic metabolic panel: methyl monensin, blood gas: glass). We questioned if the basic metabolic panel hypernatremia represents artefactual pseudohypernatremia. Design: We added vecuronium bromide or esmolol hydrochloric acid to pooled plasma samples and compared sodium values measured by both methodologies. We queried sodium results from the electronic medical records of patients admitted at Children’s Hospital of Philadelphia from 2016 to 2018 and received vecuronium and/or esmolol infusion treatment during their admissions. Setting: PICU of a quaternary, free-standing children’s hospital. Patients: Children admitted to the hospital who received vecuronium and/or esmolol infusion. Measurements and Main Results: Sodium was measured in pooled plasma samples by basic metabolic panel and blood gas methodologies after adding vecuronium bromide or esmolol hydrochloric acid, leading to a dose-response increase in basic metabolic panel sodium measurements. A repeated measures regression analysis of our electronic medical records showed that the vecuronium dose predicted the Δ sodium (basic metabolic panel–blood gas) sodium within 12 hours of the vecuronium administration (p < 0.0018). Esmolol showed a similar trend (p = 0.13). This occurred primarily in central line samples with continuous vecuronium or esmolol infusions. Conclusions: Vecuronium and esmolol can falsely elevate direct ion-selective electrode sodium measurements on Vitros chemistry analyzers. Unexpectedly high sodium measurements in patients receiving vecuronium and/or esmolol infusions should be further investigated with an alternate sample type (i.e., peripheral blood) or measurement methodology (i.e., blood gas) to guide treatment decisions.
- 1 November 2016
- Published by Elsevier in Spatial and Spatio-temporal Epidemiology
- Vol. 19, 115-124
The spatio-temporal relationship between alcohol outlets and violence before and after privatization: A natural experiment, Seattle, Wa 2010–2013
- 1 November 2016
- Published by Elsevier in Spatial and Spatio-temporal Epidemiology
- Vol. 19, 115-124
The spatio-temporal relationship between alcohol outlets and violence before and after privatization: A natural experiment, Seattle, Wa 2010–2013